Patients with obesity facing moderate to severe COVID-19 had a 20 to 50% higher risk of mortality compared to those with normal weight.
Critically ill patients given piperacillin/tazobactam had higher mortality rates than those given cefepime, possibly due to the antibiotic's impact on gut bacteria.
Low iron levels from persistent inflammation after COVID-19 infection may contribute to long COVID symptoms like fatigue and brain fog, potentially opening new avenues for prevention and treatment through iron supplementation or redistribution.
AstraZeneca initiated a global withdrawal of its COVID-19 vaccine due to declining demand and newer variant-targeting vaccines.
Research has given insights into the complex mechanisms underlying Long COVID, particularly the role of sustained inflammation.
